Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin- dalfopristin against gram-positive and -negative organisms

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 3028-3031

  Pankuch, Glenn A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; MACROLIDE; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CELL KILLING; CELL VIABILITY; DRUG EFFECT; ENTEROCOCCUS FAECALIS; GRAM POSITIVE COCCI; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031753509     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.3028     Document Type: Article

References (16)

1. Allignet, J., S. Aubert, A. Morvan, and N. El-Solh. 1996. Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics. Antimicrob. Agents Chemother. 40:2523-2528.
2. Bergeron, M., and G. Montay. 1997. The pharmacokinetics of quinupristin/ dalfopristin in laboratory animals and humans. J. Antimicrob. Chemother. 39(Suppl. A):129-138.
3. Boswell, F. J., J. M. Andrews, and R. Wise. 1994. The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC. J. Antimicrob. Chemother. 33:1219-1222.
4. Brumfitt, W., J. M. T. Hamilton-Miller, and S. Shah. 1992. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive cocci. J. Antimicrob. Chemother. 30(Suppl. A):29-37.
5. Chin, N. X., and H. C. Neu. 1992. Post-antibiotic effect of the new streptogramin RP 59500. Eur. J. Clin. Microbiol. Infect. Dis. 11:642-645.
6. Collins, L. A., G. J. Malanoski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro, and R. C. Moellering, Jr. 1993. In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob. Agents Chemother. 37:598-601.
7. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
8. Etienne, S. D., G. Montay, A. Le Liboux, A. Frydman, and J. J. Garaud. 1992. A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. J. Antimicrob. Chemother. 30(Suppl. A):123-131.
9. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
10. National Committee for Clinical Laboratory Standards. 1996. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically -fourth edition; approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. Nougayrede, A., N. Berthaud, and D. H. Bouanchaud. 1992. Post-antibiotic effects of RP 59500 with Staphylococcus aureus. J. Antimicrob. Chemother. 30(Suppl. A):101-106.
12. Odenholt-Tornqvist, I. 1993. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem. J. Antimicrob. Chemother. 31: 881-892.
13. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1998. Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms. Antimicrob. Agents Chemother. 42:1503-1505.
14. Pankuch, G. A., C. Lichtenberger, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activity of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob. Agents Chemother. 40:1653-1656.
15. Vogelman, B., and W. A. Craig. 1996. Kinetics of antimicrobial activity. J. Pediatr. 108:835-840.
16. Williams, J. D., J. P. Maskell, A. C. Whiley, and A. M. Sefton. 1997. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. J. Antimicrob. Chemother. 39(Suppl. A):41-46.